JP2011530540A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011530540A5 JP2011530540A5 JP2011522346A JP2011522346A JP2011530540A5 JP 2011530540 A5 JP2011530540 A5 JP 2011530540A5 JP 2011522346 A JP2011522346 A JP 2011522346A JP 2011522346 A JP2011522346 A JP 2011522346A JP 2011530540 A5 JP2011530540 A5 JP 2011530540A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- pharmaceutical dosage
- tetrahydrobiopterin
- form according
- metabolic precursor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002552 dosage form Substances 0.000 claims 12
- 230000002503 metabolic effect Effects 0.000 claims 9
- 239000002243 precursor Substances 0.000 claims 9
- FNKQXYHWGSIFBK-RPDRRWSUSA-N sapropterin Chemical compound N1=C(N)NC(=O)C2=C1NC[C@H]([C@@H](O)[C@@H](O)C)N2 FNKQXYHWGSIFBK-RPDRRWSUSA-N 0.000 claims 9
- 229960004617 sapropterin Drugs 0.000 claims 9
- 239000007864 aqueous solution Substances 0.000 claims 6
- 239000003963 antioxidant agent Substances 0.000 claims 5
- 230000003078 antioxidant effect Effects 0.000 claims 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- -1 sulfhydryl compound Chemical class 0.000 claims 3
- 201000011252 Phenylketonuria Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- REYLLNRLWCBKCM-YFKPBYRVSA-N (2s)-2-acetamido-4-sulfanylbutanoic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCS REYLLNRLWCBKCM-YFKPBYRVSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 1
- 206010069116 Tetrahydrobiopterin deficiency Diseases 0.000 claims 1
- 229960004308 acetylcysteine Drugs 0.000 claims 1
- 235000008452 baby food Nutrition 0.000 claims 1
- YVKSGVDJQXLXDV-BYPYZUCNSA-N ethyl (2r)-2-amino-3-sulfanylpropanoate Chemical compound CCOC(=O)[C@@H](N)CS YVKSGVDJQXLXDV-BYPYZUCNSA-N 0.000 claims 1
- FTURCWPZLPUMLY-YFKPBYRVSA-N ethyl (2s)-2-amino-4-sulfanylbutanoate Chemical compound CCOC(=O)[C@@H](N)CCS FTURCWPZLPUMLY-YFKPBYRVSA-N 0.000 claims 1
- 229960001913 mecysteine Drugs 0.000 claims 1
- GPBQMUGQGMBCNZ-BYPYZUCNSA-N methyl (2s)-2-amino-4-sulfanylbutanoate Chemical compound COC(=O)[C@@H](N)CCS GPBQMUGQGMBCNZ-BYPYZUCNSA-N 0.000 claims 1
- MCYHPZGUONZRGO-VKHMYHEASA-N methyl L-cysteinate Chemical compound COC(=O)[C@@H](N)CS MCYHPZGUONZRGO-VKHMYHEASA-N 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA1254/2008 | 2008-08-12 | ||
| AT12542008 | 2008-08-12 | ||
| PCT/AT2009/000306 WO2010017570A2 (de) | 2008-08-12 | 2009-08-07 | Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011530540A JP2011530540A (ja) | 2011-12-22 |
| JP2011530540A5 true JP2011530540A5 (https=) | 2012-06-07 |
Family
ID=41111155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011522346A Pending JP2011530540A (ja) | 2008-08-12 | 2009-08-07 | テトラヒドロビオプテリンを含有する医薬剤形 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110144117A1 (https=) |
| EP (1) | EP2309983B1 (https=) |
| JP (1) | JP2011530540A (https=) |
| ES (1) | ES2736730T3 (https=) |
| PL (1) | PL2309983T3 (https=) |
| RU (1) | RU2011109210A (https=) |
| TR (1) | TR201910287T4 (https=) |
| WO (1) | WO2010017570A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140108281A (ko) * | 2013-01-10 | 2014-09-05 | 뉴트리셔널 테라퓨틱스, 인크. | 건강 유지 및 급성 및 만성 장애의 치료를 위한 지질 보조제를 함유하는 츄어블 웨이퍼 |
| PL2926805T3 (pl) | 2014-03-31 | 2016-12-30 | Stałe kompozycje farmaceutyczne zawierające pochodne biopteryny oraz zastosowania takich kompozycji | |
| US11072614B2 (en) | 2016-11-29 | 2021-07-27 | Ptc Therapeutics Mp, Inc. | Polymorphs of sepiapterin and salts thereof |
| US11130760B2 (en) | 2016-11-29 | 2021-09-28 | Ptc Therapeutics Mp, Inc. | Polymorphic form of sepiapterin |
| JP7811085B2 (ja) * | 2017-09-01 | 2026-02-04 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリンを含む医薬組成物及びその使用 |
| EP3801536B1 (en) | 2018-05-30 | 2024-07-17 | PTC Therapeutics MP, Inc. | Administration of sepiapterin without food for use in a method for increasing sepiapterin plasma exposure |
| CN112654356A (zh) | 2018-05-30 | 2021-04-13 | Ptc医疗Mp公司 | 增加四氢生物蝶呤血浆暴露的组合物和方法 |
| JP7553906B2 (ja) * | 2018-11-01 | 2024-09-19 | 宏 一瀬 | Ｓｐｒをコードするポリヌクレオチドを含む組換えベクター、及びそれを含む組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61277618A (ja) * | 1985-06-04 | 1986-12-08 | Suntory Ltd | 自閉症治療剤 |
| JP2588191B2 (ja) * | 1987-04-24 | 1997-03-05 | サントリー株式会社 | 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤 |
| DE10260263A1 (de) * | 2002-12-20 | 2004-07-15 | Biocrates Life Sciences Gmbh | Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen |
| AU2005239939C1 (en) * | 2004-05-11 | 2011-06-30 | Daiichi Sankyo Company Limited | BH4-responsive hyperphenylalaninemia remedies |
| WO2006055511A2 (en) * | 2004-11-17 | 2006-05-26 | Biomarin Pharmaceutical Inc. | Stable tablet formulation of tetrahydrobiopterin |
| US20060188492A1 (en) * | 2005-01-13 | 2006-08-24 | Chronorx Llc, An Alaska Limited Liability Company | Topical management of ocular and periocular conditions |
| JP2008540486A (ja) * | 2005-05-11 | 2008-11-20 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｐｄｅ４インヒビター及びテトラヒドロビオプテリン誘導体との組合せ物 |
| WO2008128049A2 (en) * | 2007-04-11 | 2008-10-23 | Biomarin Pharmaceutical Inc. | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
-
2009
- 2009-08-07 US US13/058,625 patent/US20110144117A1/en not_active Abandoned
- 2009-08-07 JP JP2011522346A patent/JP2011530540A/ja active Pending
- 2009-08-07 RU RU2011109210/15A patent/RU2011109210A/ru not_active Application Discontinuation
- 2009-08-07 WO PCT/AT2009/000306 patent/WO2010017570A2/de not_active Ceased
- 2009-08-07 ES ES09775591T patent/ES2736730T3/es active Active
- 2009-08-07 PL PL09775591T patent/PL2309983T3/pl unknown
- 2009-08-07 TR TR2019/10287T patent/TR201910287T4/tr unknown
- 2009-08-07 EP EP09775591.2A patent/EP2309983B1/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011530540A5 (https=) | ||
| RU2011109210A (ru) | Лекарственная форма, содержащая тетрагидробиоптерин | |
| JP2012031131A5 (https=) | ||
| US20210205241A1 (en) | Beta-hydroxybutyric acid compositionsand methods for oral delivery of ketone bodies | |
| US20190167613A1 (en) | Mixed salt compositions for producing elevated and sustained ketosis | |
| US12533331B2 (en) | S-beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies | |
| JP2013541595A5 (https=) | ||
| AU2020221031B2 (en) | Beta-hydroxybutyrate mixed salt-acid compositions and methods of use | |
| EP2545939A3 (en) | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring | |
| RU2017134002A (ru) | Стабильные композиции тетрагидробиоптерина | |
| WO2009048148A1 (ja) | シトルリンおよびアルギニンを含有する即効性血中アルギニン濃度上昇型経口剤 | |
| JP2012515184A5 (https=) | ||
| JP2014530801A5 (https=) | ||
| JP2017507973A5 (https=) | ||
| JP2013505233A5 (https=) | ||
| JP2015505295A5 (https=) | ||
| JP2011506587A5 (https=) | ||
| HK1203050A1 (en) | Novel dosage and formulation | |
| JP2015518038A5 (https=) | ||
| WO2006040112A3 (en) | Taste-masking pharmaceutical compositions | |
| JP2011068692A5 (https=) | ||
| WO2004017955A1 (en) | L-arginine containing pharmaceutical composition | |
| HRP20200691T1 (hr) | Pedijatrijska formulacija | |
| RU2017145602A (ru) | Жидкие композиции целекоксиба для перорального введения | |
| RS60172B1 (sr) | Farmaceutska kompozicija u obliku oralne suspenzije, koja uključuje flavonoidnu frakciju i ksantan gumu |